Authors:
Seyfarth, B
Kuse, R
Sonnen, R
Glass, B
Schmitz, N
Dreger, P
Citation: B. Seyfarth et al., Autologous stem cell transplantation for follicular lymphoma: no benefit for early transplant?, ANN HEMATOL, 80(7), 2001, pp. 398-405
Authors:
Murdter, TE
Coller, J
Claviez, A
Schonberger, F
Hofmann, U
Dreger, P
Schwab, M
Citation: Te. Murdter et al., Sensitive and rapid quantification of busulfan in small plasma volumes by liquid chromatography-electrospray mass spectrometry, CLIN CHEM, 47(8), 2001, pp. 1437-1442
Authors:
Dreger, P
Viehmann, K
von Neuhoff, N
Kruss, D
Glass, B
Kneba, M
Mitsky, P
Jopp, P
Rautenberg, P
Mills, B
Schmitz, N
Citation: P. Dreger et al., A prospective study of positive/negative ex vivo B-cell depletion in patients with chronic lymphocytic leukemia, EXP HEMATOL, 28(10), 2000, pp. 1187-1196
Authors:
Dreger, P
Glass, B
Seyfarth, B
Humpe, A
Claviez, A
von Neuhoff, N
Suttorp, M
Schoch, R
Schmitz, N
Citation: P. Dreger et al., Reduced-intensity allogeneic stem cell transplantation as salvage treatment for patients with indolent lymphoma or CLL after failure of autologous SCT, BONE MAR TR, 26(12), 2000, pp. 1361-1362
Authors:
Dreger, P
Rautenberg, P
Kneba, M
Schmitz, N
Citation: P. Dreger et al., Hepatitis B viremia in a patient with documented previous HBV immunity after autologous transplantation of highly purified PRSC, BONE MAR TR, 26(1), 2000, pp. 114-115
Authors:
Michallet, M
Thiebaut, A
Dreger, P
Remes, K
Milpied, N
Santini, G
Hamon, M
Bjorkstrand, B
Kimby, E
Belhabri, A
Tanguy, ML
Apperley, JF
Citation: M. Michallet et al., Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): a report of the European Blood and Marrow Transplantation (EBMT) CLL subcommittee on behalfof the EBMT Chronic Leukaemias Working Party (CLWP), BR J HAEM, 108(3), 2000, pp. 595-601
Authors:
Wendtner, CM
Schmitt, B
Wilhelm, M
Dreger, P
Montserrat, E
Emmerich, B
Hallek, M
Citation: Cm. Wendtner et al., Redefining the therapeutic goals in chronic lymphocytic leukemia: Towards an evidence-based, risk-adapted therapy, ANN ONCOL, 10(5), 1999, pp. 505-509
Authors:
Dreger, P
Viehmann, K
von Neuhoff, N
Glaubitz, T
Petzoldt, O
Glass, B
Uharek, L
Rautenberg, P
Suttorp, M
Mills, B
Mitsky, P
Schmitz, N
Citation: P. Dreger et al., Autografting of highly purified peripheral blood progenitor cells following myeloablative therapy in patients with lymphoma: a prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recovery, BONE MAR TR, 24(2), 1999, pp. 153-161
Authors:
Dreger, P
Glass, B
Kuse, R
Sonnen, R
von Neuhoff, N
Bolouri, H
Kneba, M
Schmitz, N
Citation: P. Dreger et al., Myeloablative radiochemotherapy followed by reinfusion of purged autologous stem cells for Waldenstrom's macroglobulinaemia, BR J HAEM, 106(1), 1999, pp. 115-118